90301364 - ADC THERAPEUTICS

Information

  • Trademark
  • 90301364
  • Serial Number
    90301364
  • Filing Date
    November 05, 2020
    3 years ago
  • Transaction Date
    April 23, 2024
    a month ago
  • Status Date
    February 26, 2024
    3 months ago
  • Published for Opposition Date
    May 24, 2022
    2 years ago
  • Location Date
    February 26, 2024
    3 months ago
  • Status Code
    732
  • Current Location
    DIVISIONAL UNIT
    Employee Name
    EULIN, INGRID C
  • Attorney Docket Number
    3309.0340000
    Attorney Name
    TRACY-GENE G. DURKIN
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
3
Mark Identification
ADC THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the letters "ADC" above the word "THERAPEUTICS". A wave element extends across the letter "A" to a shared edge of the letters "D" and "C".
  • GS0051: Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
  • DS0000: "THERAPEUTICS"
Case File Event Statements
  • 11/9/2020 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/6/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/7/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/2/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/6/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2021 - 3 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/6/2021 - 3 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/5/2021 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/5/2021 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/6/2021 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/6/2021 - 2 years ago
    11 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/6/2021 - 2 years ago
    12 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/6/2021 - 2 years ago
    13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/6/2022 - 2 years ago
    14 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 4/6/2022 - 2 years ago
    15 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 4/6/2022 - 2 years ago
    16 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 4/6/2022 - 2 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/7/2022 - 2 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 4/12/2022 - 2 years ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 4/13/2022 - 2 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/13/2022 - 2 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/20/2022 - 2 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/20/2022 - 2 years ago
    23 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 5/4/2022 - 2 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/24/2022 - 2 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/24/2022 - 2 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/19/2022 - a year ago
    27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/18/2023 - a year ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2023 - a year ago
    29 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/18/2023 - a year ago
    30 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/20/2023 - a year ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/13/2023 - 10 months ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/13/2023 - 10 months ago
    33 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/13/2023 - 10 months ago
    34 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/15/2023 - 10 months ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/18/2024 - 4 months ago
    39 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 1/18/2024 - 4 months ago
    41 - SOU EXTENSION 3 FILED Type: EXT3
  • 1/18/2024 - 4 months ago
    36 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2024 - 4 months ago
    37 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 2/5/2024 - 3 months ago
    38 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/26/2024 - 3 months ago
    40 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 2/27/2024 - 3 months ago
    43 - CORRECTED NOA E-MAILED Type: NOAC
  • 2/26/2024 - 3 months ago
    42 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 2/27/2024 - 3 months ago
    44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA